SCHEMBL24670253

SCHEMBL24670253

CC(C)n1nc2nccnc2n1

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL822575 0.69 TOP2A (0.31) TOP2A
SCHEMBL12616367 0.63 TOP2A (0.37) TOP2A
SCHEMBL20283109 0.63 TOP2A (0.37) TOP2A
SCHEMBL18237766 0.62 ADORA2A (0.43)
SCHEMBL1102015 0.61
SCHEMBL29357583 0.61 ADORA2A (0.36)
SCHEMBL138622 0.61 ADORA2A (0.36)
SCHEMBL24210738 0.61 USP2 (0.38) TOP2A
SCHEMBL23119748 0.60 ADORA2B (0.44)
SCHEMBL15423531 0.59 ADORA2A (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022187693-A1 COVALENT CDK2-BINDING COMPOUNDS FOR THERAPEUTIC PURPOSES UMBRA THERAPEUTICS INC. (US) 2022-09-09 WO disclosed